Results 21 to 30 of about 2,394,283 (349)

Glucocorticoids for treating paediatric pulmonary hypertension: A novel use for a common medication [PDF]

open access: yes, 2017
Laboratory investigations have shown the role of inflammation in the pathogenesis of pulmonary hypertension and improvement after anti-inflammatory drugs.
Aggarwal, Manish, Grady, Ronald M
core   +2 more sources

Haemodynamic definitions and updated clinical classification of pulmonary hypertension

open access: yesEuropean Respiratory Journal, 2019
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterisation. Recent data from normal
G. Simonneau   +7 more
semanticscholar   +1 more source

Pulmonary Hypertension [PDF]

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2005
The modern era in cardiopulmonary medicine began in the 1940s, when Cournand and Richards pioneered right-heart catheterization. Until that time, no direct measurement of central vascular pressure had been performed in humans. Right-heart catheterization ignited an explosion of insights into function and dysfunction of the pulmonary circulation ...
Paul, McLoughlin   +2 more
openaire   +4 more sources

Metformin reverses development of pulmonary hypertension via aromatase inhibition [PDF]

open access: yes, 2016
Females are more susceptible to pulmonary arterial hypertension than males, although the reasons remain unclear. The hypoglycemic drug, metformin, is reported to have multiple actions, including the inhibition of aromatase and stimulation of AMP ...
Dean, Afshan   +4 more
core   +2 more sources

Pulmonary hypertension

open access: yes, 2011
The fundamental morphologic classification into plexogenic arteriopathy, thromboembolic pulmonary hypertension, pulmonary venous hypertension, and pulmonary hypertension associated with intrinsic lung disease and/or hypoxia, remains similar to the previous edition, but pulmonary capillary hemangiomatosis (PCH) is now viewed as a part of pulmonary ...
Andrew M. Churg, Joanne L. Wright
openaire   +4 more sources

Pulmonary hypertension [PDF]

open access: yesCanadian Journal of Cardiology, 2010
Abstract Symptoms of unexplained exertional breathlessness or symptoms out of proportion to coexistent heart or lung disease should alert the clinician to the possibility of pulmonary hypertension, and the condition should be actively sought in patients with known associated conditions, such as scleroderma, hypoxic lung disease, liver ...
Benjamin, Hibbert   +4 more
openaire   +3 more sources

Temporal Trends in Diagnostic Hemodynamics and Survival of Patients with Pulmonary Hypertension: A Single-Center Study

open access: yesLife, 2023
Advances in the diagnosis and treatment of pulmonary hypertension (PH) have gradually improved the disease course. This retrospective cohort study aims to explore the diagnostic hemodynamic profile and survival of PH patients and their temporal changes ...
Georgios E. Papadopoulos   +12 more
doaj   +1 more source

Left main bronchus compression due to main pulmonary artery dilatation in pulmonary hypertension: two case reports [PDF]

open access: yes, 2015
. Pulmonary arterial dilatation associated with pulmonary hypertension may result in significant compression of local structures. Left main coronary artery and left recurrent laryngeal nerve compression have been described.
Ariff, B   +6 more
core   +1 more source

Pulmonary hypertension: evolution of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension [PDF]

open access: yesJournal of Thoracic Disease, 2016
On May 16 th , 2016, Nick H. Kim, MD [University of California San Diego (UCSD), Division of Pulmonary, Critical Care & Sleep Medicine] delivered his keynote presentation outlining the current state of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).
Anderson, Ryan J   +2 more
openaire   +5 more sources

Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases

open access: yesERJ Open Research, 2023
Research questions Patients with severe pulmonary hypertension associated with chronic lung disease have a poor prognosis. Targeted pulmonary arterial hypertension therapies might improve exercise capacity and outcome, but there are no guidelines on ...
Romain Naud   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy